Indication

Growth failure associated with Turner's syndrome

Growth failure associated with Turner's syndrome is a primary skeletal and endocrine manifestation characterized by progressive linear growth deceleration and resultant short stature in female pediatric patients. Read more about Growth failure associated with Turner's syndrome

11 drugs 6 manufacturers

Advertisement

Drugs that treat it

Common Growth failure associated with Turner's syndrome therapies.

Showing 1–9 of 11 drugs

Filter & compare in the drug finder →Opens the drug finder with Growth failure associated with Turner's syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Growth failure associated with Turner's syndrome.

Growth failure associated with Turner's syndrome is a primary skeletal and endocrine manifestation characterized by progressive linear growth deceleration and resultant short stature in female pediatric patients.

The underlying genetic disorder involves complete or partial monosomy of the X chromosome (most commonly 45,X or mosaic variants).

This leads to haploinsufficiency of the short-stature homeobox (SHOX) gene, impairing chondrocyte proliferation and longitudinal bone development.

The clinical state typically manifests in infancy or early childhood with slowing growth velocity, an absence of the normal pubertal growth spurt due to concomitant gonadal dysgenesis, and an untreated adult height well below genetic potential.

Personalize your experience

Follow Growth failure associated with Turner's syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it